Access To Generic Reproductive Health Supplies Decades Behind Medicines? 19/09/2017 Tatum Anderson Despite a massive worldwide push to improve access to contraceptives, generic manufacturers say they’re not yet getting a good share of the pie. [Updated with response from UNFPA] Continue reading -> Malaysia Grants Compulsory Licence For Generic Sofosbuvir Despite Gilead Licence 15/09/2017 Catherine Saez A much cheaper version of a groundbreaking hepatitis C medicine is expected to be available soon for the hundreds of thousands of hepatitis C patients in Malaysia, as it decided to grant a compulsory licence to sofosbuvir, according to sources. The decision comes right after the medicine originator decided to expand its voluntary licensing scheme to four more countries, including Malaysia. [Updated] Continue reading -> Better Data On Fake Drugs Needed To Fight The Scourge 30/08/2017 Tatum Anderson The problem of fake medicines is a big one. But precisely how big? The problem is, when reporting numbers, news stories, reports and institutions have historically bundled the different kinds of medicines together, says an expert at the WHO. Continue reading -> Malaysia Inclusion In Gilead Voluntary Licence – A Product Of Compulsory Licence Pressure 24/08/2017 Guest contributor Gilead’s announcement today that they would include four middle-income countries (Malaysia, Thailand, Belarus, Ukraine) in their sofosbuvir voluntary licence was a welcome surprise, and will enable millions access to their highly effective, but exorbitantly priced, drug. The decision to include these countries, however, no doubt is a response to increasing pressure from within these countries to either issue a compulsory licence (CL) or a government use licence (GUL), invalidate the sofosbuvir patents, or block data exclusivity for the drug. Continue reading -> WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy 24/08/2017 William New A United States State Department science envoy quit yesterday in protest over US President Donald Trump's pullout from the Paris climate accord and defensive comments after violence at a white nationalist rally in Charlottesville, Virginia. But according to a press report, Peter Hotez, a past science adviser who has been a featured speaker of a UN agency and pharmaceutical industry group in Geneva, is stepping up to offer his services without concern for Trump's actions. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> WHO Influenza Watchdog Network Meeting In Geneva, Setting 5-Year Plan 18/07/2017 Catherine Saez The global network of national influenza centres is at the core of the World Health Organization system of influenza surveillance and response. All year round those national influenza centres collect, interpret and share flu samples or genetic information with the WHO so that seasonal vaccines can be manufactured, and potential pandemics adequately identified and contained. Continue reading -> WHO Study: Most Countries Have Ability To Reach Universal Health Coverage By 2030 17/07/2017 Catherine Saez A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors. Continue reading -> WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Malaysia Grants Compulsory Licence For Generic Sofosbuvir Despite Gilead Licence 15/09/2017 Catherine Saez A much cheaper version of a groundbreaking hepatitis C medicine is expected to be available soon for the hundreds of thousands of hepatitis C patients in Malaysia, as it decided to grant a compulsory licence to sofosbuvir, according to sources. The decision comes right after the medicine originator decided to expand its voluntary licensing scheme to four more countries, including Malaysia. [Updated] Continue reading -> Better Data On Fake Drugs Needed To Fight The Scourge 30/08/2017 Tatum Anderson The problem of fake medicines is a big one. But precisely how big? The problem is, when reporting numbers, news stories, reports and institutions have historically bundled the different kinds of medicines together, says an expert at the WHO. Continue reading -> Malaysia Inclusion In Gilead Voluntary Licence – A Product Of Compulsory Licence Pressure 24/08/2017 Guest contributor Gilead’s announcement today that they would include four middle-income countries (Malaysia, Thailand, Belarus, Ukraine) in their sofosbuvir voluntary licence was a welcome surprise, and will enable millions access to their highly effective, but exorbitantly priced, drug. The decision to include these countries, however, no doubt is a response to increasing pressure from within these countries to either issue a compulsory licence (CL) or a government use licence (GUL), invalidate the sofosbuvir patents, or block data exclusivity for the drug. Continue reading -> WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy 24/08/2017 William New A United States State Department science envoy quit yesterday in protest over US President Donald Trump's pullout from the Paris climate accord and defensive comments after violence at a white nationalist rally in Charlottesville, Virginia. But according to a press report, Peter Hotez, a past science adviser who has been a featured speaker of a UN agency and pharmaceutical industry group in Geneva, is stepping up to offer his services without concern for Trump's actions. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> WHO Influenza Watchdog Network Meeting In Geneva, Setting 5-Year Plan 18/07/2017 Catherine Saez The global network of national influenza centres is at the core of the World Health Organization system of influenza surveillance and response. All year round those national influenza centres collect, interpret and share flu samples or genetic information with the WHO so that seasonal vaccines can be manufactured, and potential pandemics adequately identified and contained. Continue reading -> WHO Study: Most Countries Have Ability To Reach Universal Health Coverage By 2030 17/07/2017 Catherine Saez A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors. Continue reading -> WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Better Data On Fake Drugs Needed To Fight The Scourge 30/08/2017 Tatum Anderson The problem of fake medicines is a big one. But precisely how big? The problem is, when reporting numbers, news stories, reports and institutions have historically bundled the different kinds of medicines together, says an expert at the WHO. Continue reading -> Malaysia Inclusion In Gilead Voluntary Licence – A Product Of Compulsory Licence Pressure 24/08/2017 Guest contributor Gilead’s announcement today that they would include four middle-income countries (Malaysia, Thailand, Belarus, Ukraine) in their sofosbuvir voluntary licence was a welcome surprise, and will enable millions access to their highly effective, but exorbitantly priced, drug. The decision to include these countries, however, no doubt is a response to increasing pressure from within these countries to either issue a compulsory licence (CL) or a government use licence (GUL), invalidate the sofosbuvir patents, or block data exclusivity for the drug. Continue reading -> WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy 24/08/2017 William New A United States State Department science envoy quit yesterday in protest over US President Donald Trump's pullout from the Paris climate accord and defensive comments after violence at a white nationalist rally in Charlottesville, Virginia. But according to a press report, Peter Hotez, a past science adviser who has been a featured speaker of a UN agency and pharmaceutical industry group in Geneva, is stepping up to offer his services without concern for Trump's actions. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> WHO Influenza Watchdog Network Meeting In Geneva, Setting 5-Year Plan 18/07/2017 Catherine Saez The global network of national influenza centres is at the core of the World Health Organization system of influenza surveillance and response. All year round those national influenza centres collect, interpret and share flu samples or genetic information with the WHO so that seasonal vaccines can be manufactured, and potential pandemics adequately identified and contained. Continue reading -> WHO Study: Most Countries Have Ability To Reach Universal Health Coverage By 2030 17/07/2017 Catherine Saez A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors. Continue reading -> WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Malaysia Inclusion In Gilead Voluntary Licence – A Product Of Compulsory Licence Pressure 24/08/2017 Guest contributor Gilead’s announcement today that they would include four middle-income countries (Malaysia, Thailand, Belarus, Ukraine) in their sofosbuvir voluntary licence was a welcome surprise, and will enable millions access to their highly effective, but exorbitantly priced, drug. The decision to include these countries, however, no doubt is a response to increasing pressure from within these countries to either issue a compulsory licence (CL) or a government use licence (GUL), invalidate the sofosbuvir patents, or block data exclusivity for the drug. Continue reading -> WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy 24/08/2017 William New A United States State Department science envoy quit yesterday in protest over US President Donald Trump's pullout from the Paris climate accord and defensive comments after violence at a white nationalist rally in Charlottesville, Virginia. But according to a press report, Peter Hotez, a past science adviser who has been a featured speaker of a UN agency and pharmaceutical industry group in Geneva, is stepping up to offer his services without concern for Trump's actions. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> WHO Influenza Watchdog Network Meeting In Geneva, Setting 5-Year Plan 18/07/2017 Catherine Saez The global network of national influenza centres is at the core of the World Health Organization system of influenza surveillance and response. All year round those national influenza centres collect, interpret and share flu samples or genetic information with the WHO so that seasonal vaccines can be manufactured, and potential pandemics adequately identified and contained. Continue reading -> WHO Study: Most Countries Have Ability To Reach Universal Health Coverage By 2030 17/07/2017 Catherine Saez A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors. Continue reading -> WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WIPO, IFPMA Speaker Says Despite Trump Actions, He Would Be US Science Envoy 24/08/2017 William New A United States State Department science envoy quit yesterday in protest over US President Donald Trump's pullout from the Paris climate accord and defensive comments after violence at a white nationalist rally in Charlottesville, Virginia. But according to a press report, Peter Hotez, a past science adviser who has been a featured speaker of a UN agency and pharmaceutical industry group in Geneva, is stepping up to offer his services without concern for Trump's actions. Continue reading -> Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> WHO Influenza Watchdog Network Meeting In Geneva, Setting 5-Year Plan 18/07/2017 Catherine Saez The global network of national influenza centres is at the core of the World Health Organization system of influenza surveillance and response. All year round those national influenza centres collect, interpret and share flu samples or genetic information with the WHO so that seasonal vaccines can be manufactured, and potential pandemics adequately identified and contained. Continue reading -> WHO Study: Most Countries Have Ability To Reach Universal Health Coverage By 2030 17/07/2017 Catherine Saez A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors. Continue reading -> WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Report Shows Benefits Of US Investment In Global Health R&D 03/08/2017 William New A new report from a global health advocacy group in Washington, DC shows the importance to the United States of US government investment in global health research and development and argues that more investment would have a tremendous positive impact on lives worldwide, including in fighting neglected diseases. Continue reading -> The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> WHO Influenza Watchdog Network Meeting In Geneva, Setting 5-Year Plan 18/07/2017 Catherine Saez The global network of national influenza centres is at the core of the World Health Organization system of influenza surveillance and response. All year round those national influenza centres collect, interpret and share flu samples or genetic information with the WHO so that seasonal vaccines can be manufactured, and potential pandemics adequately identified and contained. Continue reading -> WHO Study: Most Countries Have Ability To Reach Universal Health Coverage By 2030 17/07/2017 Catherine Saez A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors. Continue reading -> WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The Case For Nations To Act On Medicines Access 23/07/2017 William New NEW YORK -- A range of speakers, including top health officials from both a developed and developing country, last week laid out the case for why the world’s leaders must now launch a shift in the way medicines all populations need are developed and priced. The need for global collaboration is clear, speakers said, but who will lead? Continue reading -> WHO Influenza Watchdog Network Meeting In Geneva, Setting 5-Year Plan 18/07/2017 Catherine Saez The global network of national influenza centres is at the core of the World Health Organization system of influenza surveillance and response. All year round those national influenza centres collect, interpret and share flu samples or genetic information with the WHO so that seasonal vaccines can be manufactured, and potential pandemics adequately identified and contained. Continue reading -> WHO Study: Most Countries Have Ability To Reach Universal Health Coverage By 2030 17/07/2017 Catherine Saez A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors. Continue reading -> WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Influenza Watchdog Network Meeting In Geneva, Setting 5-Year Plan 18/07/2017 Catherine Saez The global network of national influenza centres is at the core of the World Health Organization system of influenza surveillance and response. All year round those national influenza centres collect, interpret and share flu samples or genetic information with the WHO so that seasonal vaccines can be manufactured, and potential pandemics adequately identified and contained. Continue reading -> WHO Study: Most Countries Have Ability To Reach Universal Health Coverage By 2030 17/07/2017 Catherine Saez A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors. Continue reading -> WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Study: Most Countries Have Ability To Reach Universal Health Coverage By 2030 17/07/2017 Catherine Saez A new study by the World Health Organization finds that most countries will have the technological and the financial ability to reach universal health coverage in the next 13 years, according to authors. Continue reading -> WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> Posts navigation Older Posts Newer Posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WIPO’s Gurry: Artificial Intelligence, Gene Editing Latest ‘Winners’ In Innovation 13/07/2017 Elise De Geyter The main winners of innovation are technologies that enable market application, with gene editing and artificial intelligence as two examples, Francis Gurry, director general of the World Intellectual Property Organization, told a panel discussion last week. Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), said at the same event that everybody benefits from innovation. Continue reading -> Posts navigation Older Posts Newer Posts